ZAI LAB LTD-ADR
ZLABNASDAQEarnings Nov 5 · PreUS Equity
$22.36▼ $0.68 (−2.95%)
🌅 Pre-market$22.40▲ 0.18%Regular close · extended-hours price shownTrack ZLAB
Get earnings, price moves & breaking news on Telegram
24h▼ 3.0%
7d▼ 7.0%
14d▼ 3.5%
30d▼ 15.0%
ytd▲ 26.8%
1y▼ 12.3%
🏦Market Cap
$25.44B
Mid Cap
📈Revenue Growth (YoY)
5.1%
Slowing
📊Gross Margin
60.5%
High
💵FCF Margin
—
⚖️P/S Ratio
5.9x
Fair
Otter Score
64
Fair
ZAI LAB LTD-ADR
ZLABAnalyst Ratings
Price
$22.36
Total
11
Raised
0
Lowered
1
Avg PT
$53.75
H / L
$75 / $35
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Reiterated | Buy | 2026-08-07 | — | — |
JP Morgan | Reiterated | Overweight | 2026-03-18 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-02-27 | — | — |
Leerink Partners | Reiterated | Outperform | 2025-06-30 | — | — |
B of A Securities | Downgraded | Buy → Neutral | 2025-03-03 | — | — |
Goldman Sachs | Reiterated | Buy | 2023-10-26 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-05-11 | — | — |
Bernstein | Reiterated | Market Perform → Perform | 2021-10-12 | — | — |
China Renaissance | Reiterated | Buy | 2019-09-04 | — | — |
Macquarie | Reiterated | Outperform | 2019-07-05 | — | — |
Credit Suisse | Reiterated | Outperform | 2019-01-29 | — | — |
Institution
Citigroup
Reiterated · Buy · 2026-08-07
—
—
JP Morgan
Reiterated · Overweight · 2026-03-18
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-02-27
—
—
Leerink Partners
Reiterated · Outperform · 2025-06-30
—
—
B of A Securities
Downgraded · Buy → Neutral · 2025-03-03
—
—
Goldman Sachs
Reiterated · Buy · 2023-10-26
—
—
SVB Leerink
Reiterated · Outperform · 2022-05-11
—
—
Bernstein
Reiterated · Market Perform → Perform · 2021-10-12
—
—
China Renaissance
Reiterated · Buy · 2019-09-04
—
—
Macquarie
Reiterated · Outperform · 2019-07-05
—
—
Credit Suisse
Reiterated · Outperform · 2019-01-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space